Scholtz-Dumas psoriasis small plaque bioassay

Journal of Dermatological Treatment

Volumn 11, Issue 1, 2000, Pages 15-19

  Katz, Martin ^a   Shaikh, Zafar ^a   Maibach, Howard I ^b  

^a Synymed Inc   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bioassay; Corticoids; Formulation; Psoriasis; Vasoconstrictor; Vehicle

Indexed keywords

BETAMETHASONE VALERATE; CLOBETASOL PROPIONATE; CORTICOSTEROID; DRUG VEHICLE; FLUMOXONIDE; FLUOCINOLONE ACETONIDE; NAPHTHALENE;

ARTICLE; BIOASSAY; BIOEQUIVALENCE; CONTROLLED STUDY; CREAM; DOSE RESPONSE; DRUG SCREENING; GEL; HUMAN; OINTMENT; PRIORITY JOURNAL; PSORIASIS; REPRODUCIBILITY; SCORING SYSTEM;

EID: 0034065688     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/095466300750163717     Document Type: Article

References (6)

1. Lauerma AI, Maibach HI, Psoriasis small plaque assay for assignment of topical drug activity. In: Roenigk HH, Maibach HI (eds) Psoriasis, 3rd edition. Marcel Dekker: New York, 1998, p. 815.
2. Dumas KJ, Scholtz JR, The psoriasis bioassay for topical corticosteroid activity. Acta Denn Venereol (1972) 52: 43-8.
3. Trozak DJ, Topical corticosteroid therapy in psoriasis vulgaris. Cutis (1990) 46: 341-50.
4. Interim Guidance: Topical Corticosteroids, July 1, 1992. FDA Division of Bioequivalence. Food and Drug Administration: Rockville, MD.
5. Jones GH, Venuti MC, Young JM, Topical nonsteroidal antipsoriatic agents. J Med Chem (1986) 29: 1504-11.
6. Leow YH, Leow HM, Role of occlusion in corticoid therapy of psoriasis. J Dermatol Treat (1997) 8: 265-9.